gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · SBFMHealthcarePharmaceuticals

Sunshine Biopharma Inc. (SBFM)

$2.65−3.28%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$2.65▼ 99.22% in range
Nov 4, 2025Low $2.65 · High $508.20Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Sunshine Biopharma closed at $2.65 on Nov 4, down 3.28%, within 0.0% of its 52-week closing low. Volume of 88.2K shares was 0.01× its 20-day average (below normal).

Split-adjusted performance: -66.7% over one month, -98.8% over six months, -99.2% over one year.

In the quarter ended Jun 30, 2026, revenue was $9.26M, down 1.6% from a year earlier, with a net margin of -16.9%.

Short interest was 840.9K shares at the Oct 15 settlement, up 539.6% from the prior report (5.9% of float, 1.0 days to cover).

Market cap$2.0M741.0K shares
Revenue · quarter$9.3M−1.6% YoY
Diluted EPS$-23.00—
P/E · TTM—P/S 0.1×
Net margin-16.9%Gross 26.2%
Dividend yieldNone
52-week range2.65 – 508.20−99.5% from high
Volume88.2K0.01× 20-day avg
Volatility · 60d896.4%Annualised
Short % of float5.9%1.0 days to cover
Net cash$13.7MCash $13.7M
Next earnings—Not scheduled
Split-adjusted performance
1W −14.8%1M −66.7%3M −90.5%6M −98.8%YTD −98.9%1Y −99.2%3Y −100.0%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum1
Revenue growth40
Net margin59
Value (low P/E)—
Size4

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short840.9K+539.6% vs prior
Days to cover1.0Settled Oct 15
% of float5.9%
Short vol. 10d57.1%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
SBFMSunshine Biopharma$2.65−3.28%−98.8%−1.6%−16.9%—$2.0M
PPCBPropanc Biopharma$1.79+4.68%−92.9%———$1.8MCompare
GNPXGenprex$2.14−7.36%−89.1%———$1.8MCompare
OGENOragenics$0.3720+0.51%−40.0%———$1.7MCompare
ERNAErnexa Therapeutics$1.99−1.49%−67.1%———$2.3MCompare
KAPAKairos Pharma$0.4897−3.03%−87.4%———$1.7MCompare
KPTIKaryopharm Therapeutics$0.0729−17.44%−99.2%−11.9%−200.5%—$1.7MCompare
REVBRevelation Biosciences$4.12−7.05%−42.3%———$2.3MCompare
HCWBHCW Biologics$1.08−6.09%−48.6%+1969.7%−11340.3%—$2.4MCompare

News about Sunshine Biopharma

All news →
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours TodayBenzinga · May 29, 2026▼ Negative

Quick answers

What does Sunshine Biopharma do?
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements.
What is SBFM's market cap?
$1.96M, based on the Nov 4 close of $2.65.
Does Sunshine Biopharma pay a dividend?
No regular cash dividend has been paid in the last year.
How much of SBFM is sold short?
840.9K shares, 5.9% of float, as of Oct 15, 2026.
What sector is SBFM in?
Healthcare, in the Pharmaceuticals industry.

About Sunshine Biopharma

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

HQ: Fort Lauderdale, FL50 employeesListed Aug 9, 2007sunshinebiopharma.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology